Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Mehrdad Hefazi, MD, Reona Sakemura, MD PhD, Saad S. Kenderian, MD, Mrinal M Patnaik, MDMBBS, William J Hogan, MB, BCh, Mark Litzow, MD, Hemang Yadav, MBBS

Blood (2019) 134 (Supplement_1): 4500.

https://doi.org/10.1182/blood-2019-132133

Published: 2019

Journal Articles

Cellular and Molecular Architecture of Hematopoietic Stem Cells and Progenitors in Genetic Models of Bone Marrow Failure

Stephanie C. Heidemann, MD, Brian Bursic, Sasan Zandi, MD PhD, Hongbing Li, PhD, Robert J Klaassen, MD FRCPC, Sharon Abish, MD, Meera Rayar, Vicky R. Breakey, BSc,MDFRCPC, Houtan Moshiri, PhD, Santhosh Dhanraj, PhD, Richard de Borja, PhD, Adam Shlien, PhD, John E. Dick, PhD, Yigal Dror, MDFRCPC, Sagi Abelson, PhD

Blood (2019) 134 (Supplement_1): 1223.

https://doi.org/10.1182/blood-2019-130534

Published: 2019

Journal Articles

Genomic Profiles and Subset Characterization of CD8 + terminally Differentiated Effector Memory (T EMRA ) Cells from Cancer Patients

Deok-Hwan Yang, MD PhD, Jae-Sook Ahn, Seo-Yeon Ahn, MD, Sung-Hoon Jung, MD, Je-Jung Lee, MD PhD, Hyeoung-Joon Kim, MD PhD, Young Rok Do, PhDMD, Sang Yun Song, MD PhD, Ga-Young Song, Hyeong Jong Kim, MD, Theresa Kim

Blood (2019) 134 (Supplement_1): 2329.

https://doi.org/10.1182/blood-2019-126533

Published: 2019

Journal Articles

Preclinical Assessment of Non-Virally Engineered CD33.CAR Cytokine-Induced Killer (CIK) Cells in Chemoresistant AML Patient-Derived Xenografts

Maria Caterina Rotiroti, PhD, Chiara Buracchi, PhD, Silvia Arcangeli, PhD, Chiara F Magnani, PhD, Claudia Cappuzzello, PhD, Zsuzsanna Izsvak, PhD, Stefania Galimberti, PhD, Maria Grazia Valsecchi, PhD, Giuseppe Dastoli, MD, Marta Serafini, PhD, Ettore Biagi, MD, Andrea Biondi, MD, Sarah Tettamanti, PhD

Blood (2019) 134 (Supplement_1): 2665.

https://doi.org/10.1182/blood-2019-130399

Published: 2019

Journal Articles

Kaposiform Lymphangiomatosis: Update on Outcomes and Use of Sirolimus As a Therapeutic Intervention

Whitney Eng, MD, Hasan Al-Sayegh, Clement Ma, PhD, Denise Adams, MD

Blood (2018) 132 (Supplement 1): 3734.

https://doi.org/10.1182/blood-2018-99-110989

Published: 2018

Journal Articles

Ruxolitinib and Steroid Refractory/Dependent Bronchiolitis Obliterans after Hematopoietic Cell Transplantation: A Steroid Sparing Agent That Also Resulted in Improved Lung Function in Children

Michelle Schoettler, MD, Meera Subramaniam, MD, Steven P. Margossian, MD PhD

Blood (2018) 132 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2018-99-114971

Published: 2018

Journal Articles

Integrated Proteomic and Phosphoproteomic Analysis Reveal Novel Targets and Suggest Rationale for Ibrutinib Efficacy in UM-CLL

Laura Beckmann, MD, Valeska Berg, PhD, Clarissa Dickhut, Johannes Bloehdorn, MD, Jasmin Bahlo, PhD, Sandra Robrecht, PhD, Malte Hülsemann, MD, Stefan Loroch, Olaf Merkel, Kirsten Fischer, MD, Clemens-Martin Wendtner, Stephan Stilgenbauer, Albert Sickmann, PhD, Michael Hallek, René Zahedi, PhD, Lukas P. Frenzel, MD

Blood (2018) 132 (Supplement 1): 583.

https://doi.org/10.1182/blood-2018-99-118235

Published: 2018

Journal Articles

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD MPH, Anja C. Roden, MD, Mrinal M. Patnaik, MD MBBS, Reona Sakemura, MD PhD, Nandita Khera, MD, Vivek Roy, MD, Cassie C. Kennedy, MD, William J. Hogan, MB, BCh, Mark R. Litzow, MD, Hemang Yadav, MBBS

Blood (2018) 132 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2018-99-118930

Published: 2018

Journal Articles

Diagnosis and Management of Paget-Schroetter Syndrome in Children: An Institutional Experience

Katherine L Harsh, BS, Surbhi Saini, MD, Joseph R Stanek, MS, Sarah O'Brien, MD MSc, Patrick Warren, MD, Riten Kumar, MDMSc

Blood (2017) 130 (Supplement 1): 699.

https://doi.org/10.1182/blood.V130.Suppl_1.699.699

Published: 2017

Journal Articles

The Anaphase Promoting Complex/Cyclosome: A New Promising Target in Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma

Anke Maes, Eva De Smedt, Kim De Veirman, Ken Maes, Eline Menu, PhD, Els Van Valckenborgh, PhD, Karin Vanderkerken, PhD, Elke De Bruyne, PhD

Blood (2017) 130 (Supplement 1): 2757.

https://doi.org/10.1182/blood.V130.Suppl_1.2757.2757

Published: 2017

Journal Articles

T-cell expression of AhR inhibits the maintenance of pT reg cells in the gastrointestinal tract in acute GVHD

Trisha A. Dant, Kaifeng L. Lin, Danny W. Bruce, Stephanie A. Montgomery, Oleg V. Kolupaev, Hemamalini Bommiasamy, Lisa M. Bixby, John T. Woosley, Karen P. McKinnon, Frank J. Gonzalez, Bruce R. Blazar, Benjamin G. Vincent, James M. Coghill, Jonathan S. Serody

Blood (2017) 130 (3): 348–359.

https://doi.org/10.1182/blood-2016-08-734244

Published: 2017

Includes: Supplemental data

Journal Articles

Spontaneous Post-Transplant Air-Leak Syndrome in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Sheng-Hsuan Chien, MD, Yao-Chung Liu, MD, Nai-Wen Fan, MD, Chia-Jen Liu, PhD, Tzeon-Jye Chiou, MD, Cheng-Hwai Tzeng, MD, Jyh-Pyng Gau, MD, Jin-Hwang Liu, MD PhD

Blood (2016) 128 (22): 5780.

https://doi.org/10.1182/blood.V128.22.5780.5780

Published: 2016

Journal Articles

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Ramon Garcia-Sanz, MD PhD, Anna Sureda, MD PhD, Ana Pilar Gonzalez, MD, Fatima De la Cruz, MD PhD, Blanca Sanchez-Gonzalez, MD PhD, Antonia Rodriguez, MD PhD, Eva Domingo-Domenech, MD, Moreno Miriam, MD, Moreno Miriam, MD, Javier Lopez, Sr., MD PhD, Piñana Luis Jose, Gabriela Rodríguez, MD PhD, Miguel Canales, MD PhD, Antonio Gutierrez, MD PhD, Maria Dolores Caballero, MD PhD, Carmen Martinez, MD PhD

Blood (2016) 128 (22): 1109.

https://doi.org/10.1182/blood.V128.22.1109.1109

Published: 2016

Journal Articles

Ruxolitinib (RUX) in Combination with Azacytidine (AZA) in Patients (pts) with Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Naval G. Daver, MD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Elias J. Jabbour, MD, Prithviraj Bose, MD, Lingsha Zhou, Sherry Pierce, BSN, BA, Stephanie Van Derbur, Carla Kay Tuttle, RN, Gautam Borthakur, MD, Zeev Estrov, MD, Guillermo Garcia-Manero, MD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD PhD

Blood (2016) 128 (22): 4246.

https://doi.org/10.1182/blood.V128.22.4246.4246

Published: 2016

Journal Articles

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies

Nakul Singhal, MD, Rashi Sharma, MD, Ashwin Chandar, MD, Vincent McAuliffe, MD, Dennis L Cooper, MD

Blood (2016) 128 (22): 2412.

https://doi.org/10.1182/blood.V128.22.2412.2412

Published: 2016

Journal Articles

5-Azacytidine (AZA) in Combination with Ruxolitinib (RUX) As Therapy for Patients (pts) with Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Naval Daver, MD, Guillermo Garcia-Manero, MD, Jorge E. Cortes, MD, Lingsha Zhou, Sherry Pierce, BSN, BA, Naveen Pemmaraju, MD, Elias Jabbour, Courtney DiNardo, MD, Tapan Kadia, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Marina Konopleva, MD PhD, Franklin Wynn, Stephanie Van Derbur, Zeev Estrov, MD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD

Blood (2015) 126 (23): 823.

https://doi.org/10.1182/blood.V126.23.823.823

Published: 2015

Journal Articles

Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Ramon Garcia-Sanz, MDPhD, Anna Sureda, MD PhD, Sara Alonso-Alvarez, MD, Ana Pilar Gonzalez, MD, Antonia Rodriguez, MD PhD, Antonio Salar, MD PhD, Fatima de la Cruz, MD, Eva Domingo, MD, Miriam Moreno, MD, Javier Lopez, Sr., MD PhD, Jose Luis Piñana, MD, Gabriela Rodriguez, Miguel Canales, Antonio Manuel Gurierrez, MD, Armando López-Guillermo, MD, María Dolores Caballero, MD PhD, Silvia Jimenez, BsC, Carmen Martinez, MD PhD

Blood (2015) 126 (23): 582.

https://doi.org/10.1182/blood.V126.23.582.582

Published: 2015

Journal Articles

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Nicola Stefano Fracchiolla, MD, Elisabetta Todisco, MD PhD, Andrea Bilancia, Sara Gandolfi, MD, Valentina Mancini, MD, Laura Marbello, MD, Massimo Bernardi, MD, Andrea Assanelli, MD, Nicola Orofino, MD, Ramona Cassin, MD, Mariarita Sciumè, MD, Francesca Guidotti, MD, Roberto Cairoli, MD, Fabio Ciceri, MD, Armando Santoro, MD, Agostino Cortelezzi, MD, Giuseppe Rossi, MD

Blood (2015) 126 (23): 5611.

https://doi.org/10.1182/blood.V126.23.5611.5611

Published: 2015

Journal Articles

Influence of the Insertion Site on Central Venous Catheter Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation, High Dose Therapy or Induction Therapy for Acute Leukemia

Daniela Heidenreich, Eleonore Muetzel, Sebastian Kreil, Florian Nolte, Melanie Faust, Mohamad Jawhar, Anna Hecht, Wolf-Karsten Hofmann, Stefan A. Klein

Blood (2015) 126 (23): 1919.

https://doi.org/10.1182/blood.V126.23.1919.1919

Published: 2015

Journal Articles

The Use of Temporary Central Venous Catheters for Optimizing Continuous Infusion in Hemophilia Patients Undergoing Major Surgical Procedures

Ana Boban, MD PhD, Catherine M Lambert, MD, Cedric R. Hermans, MD PhD

Blood (2014) 124 (21): 2822.

https://doi.org/10.1182/blood.V124.21.2822.2822

Published: 2014

NARROW

Risks and Benefits of Bronchoscopy during the First 100 Days Following Allogeneic Hematopoietic Cell Transplantation

Cellular and Molecular Architecture of Hematopoietic Stem Cells and Progenitors in Genetic Models of Bone Marrow Failure

Genomic Profiles and Subset Characterization of CD8 + terminally Differentiated Effector Memory (T EMRA ) Cells from Cancer Patients

Preclinical Assessment of Non-Virally Engineered CD33.CAR Cytokine-Induced Killer (CIK) Cells in Chemoresistant AML Patient-Derived Xenografts

Kaposiform Lymphangiomatosis: Update on Outcomes and Use of Sirolimus As a Therapeutic Intervention

Ruxolitinib and Steroid Refractory/Dependent Bronchiolitis Obliterans after Hematopoietic Cell Transplantation: A Steroid Sparing Agent That Also Resulted in Improved Lung Function in Children

Integrated Proteomic and Phosphoproteomic Analysis Reveal Novel Targets and Suggest Rationale for Ibrutinib Efficacy in UM-CLL

Histopathologic Acute Lung Injury after Allogeneic Hematopoietic Cell Transplantation: Clinical Findings, Radiologic Features, Treatments and Outcomes

Diagnosis and Management of Paget-Schroetter Syndrome in Children: An Institutional Experience

The Anaphase Promoting Complex/Cyclosome: A New Promising Target in Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma

T-cell expression of AhR inhibits the maintenance of pT reg cells in the gastrointestinal tract in acute GVHD

Spontaneous Post-Transplant Air-Leak Syndrome in Adult Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Ruxolitinib (RUX) in Combination with Azacytidine (AZA) in Patients (pts) with Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies

5-Azacytidine (AZA) in Combination with Ruxolitinib (RUX) As Therapy for Patients (pts) with Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Influence of the Insertion Site on Central Venous Catheter Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation, High Dose Therapy or Induction Therapy for Acute Leukemia

The Use of Temporary Central Venous Catheters for Optimizing Continuous Infusion in Hemophilia Patients Undergoing Major Surgical Procedures

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only